Report from EGM 12 June 2019
Bio-Works publishes the report from its Extraordinary General Meeting held on 12 June 2019.
Bio-Works present at Småbolagsdagen
Bio-Works participates in Småbolagsdagen, presenting its business and growth strategy to Swedish investors and analysts.
Quarterly report Q1 2019
Bio-Works releases its Q1 2019 quarterly report covering financial performance and key operational developments.
Presentation at Vator Securities Unicorn Summit
Mats Johnson, CEO of Bio-Works, will be presenting at the Vator Securities Unicorn Summit on Thursday [...]
Investment presentation at BioStock
Bio-Works presents investment case at BioStock, highlighting its technology and growth opportunities in Nordic life sciences.
Bio-Works is now ISO 9001:2015 certified
Bio-Works achieves ISO 9001:2015 certification, demonstrating its commitment to quality management and regulatory compliance.
Bokslutskommuniké Januari – december 2018
Bio-Works publicerar sin bokslutskommuniké för januari–december 2018 med finansiella resultat och viktiga händelser.
Bio-Works increased customer base by 125 % during 2018
Press release February 7, 2019 Bio-Works had 236 active customers at the end of 2018. [...]
WorkBeads affimAb launched
Bio-Works launches WorkBeads affimAb, a novel affinity resin designed for the purification of next-generation biological pharmaceuticals.
Bio-Works increases target for the number of new customers 2018
Bio-Works raises its new customer target for 2018, reflecting strong commercial momentum and growing market demand.
